Non-sugar sweeteners and cancer: Toxicological and epidemiological evidence
Several toxicological and epidemiological studies were published during the last five decades on non-sugar sweeteners (NSS) and cancer. Despite the large amount of research, the issue still continues to be of interest. In this review, we provided a comprehensive quantitative review of the toxicologi...
Gespeichert in:
Veröffentlicht in: | Regulatory toxicology and pharmacology 2023-03, Vol.139, p.105369-105369, Article 105369 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Several toxicological and epidemiological studies were published during the last five decades on non-sugar sweeteners (NSS) and cancer. Despite the large amount of research, the issue still continues to be of interest. In this review, we provided a comprehensive quantitative review of the toxicological and epidemiological evidence on the possible relation between NSS and cancer. The toxicological section includes the evaluation of genotoxicity and carcinogenicity data for acesulfame K, advantame, aspartame, cyclamates, saccharin, steviol glycosides and sucralose. The epidemiological section includes the results of a systematic search of cohort and case-control studies. The majority of the 22 cohort studies and 46 case-control studies showed no associations. Some risks for bladder, pancreas and hematopoietic cancers found in a few studies were not confirmed in other studies. Based on the review of both the experimental data on genotoxicity or carcinogenicity of the specific NSS evaluated, and the epidemiological studies it can be concluded that there is no evidence of cancer risk associated to NSS consumption.
•No consistent evidence of carcinogenicity from epidemiological studies on NSS use.•Epidemiological studies on NSS use show heterogeneity due to several factors.•No evidence relevant to humans of carcinogenicity in animals.•Advice against the use of NSS is not warranted on the basis of cancer risk. |
---|---|
ISSN: | 0273-2300 1096-0295 |
DOI: | 10.1016/j.yrtph.2023.105369 |